Anjarium Biosciences AG

Anjarium Biosciences AG is a biotechnology company focused on creating and delivering a new generation of non-viral gene therapies to treat serious genetic diseases. The company develops a versatile platform that combines proprietary DNA-based gene vectors and targeted delivery technologies to optimize the discovery and delivery cycle of genetic medicines, providing more predictable and enduring ways to address genetic diseases throughout a patient's lifetime.